| HEIDELBERG PHARMA AG O.N. |
| Deutschland |
| Gesundheit |
| DE000A11QVV0 / A11QVV |
| HPHA (Frankfurt) |
| FRA:HPHA, ETR:HPHA, HPHA:GR |
| - |
| https://heidelberg-pharma.. |
|
Heidelberg Pharma AG is a clinical-stage biopharmaceutical company specializing in oncology, developing innovative antibody-drug conjugates (ADCs) for targeted cancer therapies. Its primary focus is o..
>Volltext.. |
| 143.04 Mio. EUR |
| 156.77 Mio. EUR |
| 3.05 Mio. EUR |
| -30.97 Mio. EUR |
| -26.32 Mio. EUR |
| -0.56 EUR |
| 36.81 Mio. EUR |
| 23 Mio. EUR |
| -31.83 Mio. EUR |
| 3.27 |
| -64.15% |
| -39.49% |
| - |
| - |
| - |
| - |
| HEIDELBERG PHARMA, WILEX |
| 09.03.26 |
|